Request Appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Rosenbaum
Dr. Evan Rosenbaum is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 5 years. He is one of 505 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 30 publications and over 500 citings.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2014 - 2017
- Albert Einstein College of MedicineClass of 2014
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2020 - 2027
- NY State Medical License 2016 - 2025
- NC State Medical License 2021 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma Start of enrollment: 2020 Sep 29
- A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma Start of enrollment: 2023 May 23
- A Study of Immunotherapy Treatment in People With Sarcoma Start of enrollment: 2023 Oct 27
- Join now to see all
Publications & Presentations
PubMed
- Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors.Ciara M Kelly, Martina Bradic, Sara Saunds, Viswatej Avutu, Lauren Banks
Clinical Cancer Research. 2025-07-22 - 1 citationsPhase II study of rucaparib and nivolumab in patients with leiomyosarcoma.Sujana Movva, Kenneth Seier, Martina Bradic, Karmelina Charalambous, Evan Rosenbaum
Journal for Immunotherapy of Cancer. 2025-06-12 - Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade.Olayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, Martina Bradic, Bernard O'Malley
NPJ Precision Oncology. 2025-03-25
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: